| Title |
Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management
|
|---|---|
| Published in |
Eye and Brain, September 2017
|
| DOI | 10.2147/eb.s125311 |
| Pubmed ID | |
| Authors |
Shauna Berry, Weijie V Lin, Ama Sadaka, Andrew G Lee |
| Abstract |
Nonarteritic anterior ischemic optic neuropathy (NAION) is the most common form of ischemic optic neuropathy and the second most common optic neuropathy. Patients are generally over the age of 50 years with vasculopathic risk factors (eg, diabetes mellitus, hypertension, and obstructive sleep apnea). The exact mechanism of NAION is not fully understood. In addition, several treatment options have been proposed. This article summarizes the current literature on the diagnosis, treatment, and management of NAION. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 25% |
| Unknown | 3 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 111 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 12 | 11% |
| Student > Master | 11 | 10% |
| Student > Postgraduate | 10 | 9% |
| Other | 8 | 7% |
| Student > Ph. D. Student | 8 | 7% |
| Other | 18 | 16% |
| Unknown | 44 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 42 | 38% |
| Nursing and Health Professions | 9 | 8% |
| Neuroscience | 5 | 5% |
| Agricultural and Biological Sciences | 3 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
| Other | 2 | 2% |
| Unknown | 48 | 43% |